242 related articles for article (PubMed ID: 28893789)
1. Gemini Cationic Amphiphiles Control Biofilm Formation by Bacterial Vaginosis Pathogens.
Algburi A; Zhang Y; Weeks R; Comito N; Zehm S; Pinto J; Uhrich KE; Chikindas ML
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893789
[TBL] [Abstract][Full Text] [Related]
2. Cationic amphiphiles against Gardnerella vaginalis resistant strains and bacterial vaginosis-associated pathogens.
Weeks RM; Moretti A; Song S; Uhrich KE; Karlyshev AV; Chikindas ML
Pathog Dis; 2019 Nov; 77(8):. PubMed ID: 31603505
[TBL] [Abstract][Full Text] [Related]
3. Natural antimicrobials subtilosin and lauramide arginine ethyl ester synergize with conventional antibiotics clindamycin and metronidazole against biofilms of Gardnerella vaginalis but not against biofilms of healthy vaginal lactobacilli.
Algburi A; Volski A; Chikindas ML
Pathog Dis; 2015 Jul; 73(5):. PubMed ID: 25838136
[TBL] [Abstract][Full Text] [Related]
4. Screening of Compounds against Gardnerella vaginalis Biofilms.
Gottschick C; Szafranski SP; Kunze B; Sztajer H; Masur C; Abels C; Wagner-Döbler I
PLoS One; 2016; 11(4):e0154086. PubMed ID: 27111438
[TBL] [Abstract][Full Text] [Related]
5. The Natural Antimicrobial Subtilosin A Synergizes with Lauramide Arginine Ethyl Ester (LAE), ε-Poly-L-lysine (Polylysine), Clindamycin Phosphate and Metronidazole, Against the Vaginal Pathogen Gardnerella vaginalis.
Cavera VL; Volski A; Chikindas ML
Probiotics Antimicrob Proteins; 2015 Jun; 7(2):164-71. PubMed ID: 25588687
[TBL] [Abstract][Full Text] [Related]
6. Using an in-vitro biofilm model to assess the virulence potential of bacterial vaginosis or non-bacterial vaginosis Gardnerella vaginalis isolates.
Castro J; Alves P; Sousa C; Cereija T; França Â; Jefferson KK; Cerca N
Sci Rep; 2015 Jun; 5():11640. PubMed ID: 26113465
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of the two microorganisms Lactobacillus fermentum LF15 and Lactobacillus plantarum LP01, formulated in slow-release vaginal tablets, in women affected by bacterial vaginosis: a pilot study.
Vicariotto F; Mogna L; Del Piano M
J Clin Gastroenterol; 2014; 48 Suppl 1():S106-12. PubMed ID: 25291116
[TBL] [Abstract][Full Text] [Related]
8. Lysozyme as a cotreatment during antibiotics use against vaginal infections: An in vitro study on Gardnerella vaginalis biofilm models.
Thellin O; Zorzi W; Zorzi D; Delvenne P; Heinen E; ElMoualij B; Quatresooz P
Int Microbiol; 2016 Jun; 19(2):101-107. PubMed ID: 27845497
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic resistance of Gardnerella vaginalis in recurrent bacterial vaginosis.
Nagaraja P
Indian J Med Microbiol; 2008; 26(2):155-7. PubMed ID: 18445953
[TBL] [Abstract][Full Text] [Related]
10. The biofilm in bacterial vaginosis: implications for epidemiology, diagnosis and treatment.
Verstraelen H; Swidsinski A
Curr Opin Infect Dis; 2013 Feb; 26(1):86-9. PubMed ID: 23221767
[TBL] [Abstract][Full Text] [Related]
11. DNase inhibits Gardnerella vaginalis biofilms in vitro and in vivo.
Hymes SR; Randis TM; Sun TY; Ratner AJ
J Infect Dis; 2013 May; 207(10):1491-7. PubMed ID: 23431033
[TBL] [Abstract][Full Text] [Related]
12. Analysis of adherence, biofilm formation and cytotoxicity suggests a greater virulence potential of Gardnerella vaginalis relative to other bacterial-vaginosis-associated anaerobes.
Patterson JL; Stull-Lane A; Girerd PH; Jefferson KK
Microbiology (Reading); 2010 Feb; 156(Pt 2):392-399. PubMed ID: 19910411
[TBL] [Abstract][Full Text] [Related]
13. Treatment of biofilms in bacterial vaginosis by an amphoteric tenside pessary-clinical study and microbiota analysis.
Gottschick C; Deng ZL; Vital M; Masur C; Abels C; Pieper DH; Rohde M; Mendling W; Wagner-Döbler I
Microbiome; 2017 Sep; 5(1):119. PubMed ID: 28903767
[TBL] [Abstract][Full Text] [Related]
14. Influence of Biofilm Formation by Gardnerella vaginalis and Other Anaerobes on Bacterial Vaginosis.
Machado A; Cerca N
J Infect Dis; 2015 Dec; 212(12):1856-61. PubMed ID: 26080369
[TBL] [Abstract][Full Text] [Related]
15. Gardnerella vaginalis outcompetes 29 other bacterial species isolated from patients with bacterial vaginosis, using in an in vitro biofilm formation model.
Alves P; Castro J; Sousa C; Cereija TB; Cerca N
J Infect Dis; 2014 Aug; 210(4):593-6. PubMed ID: 24596283
[TBL] [Abstract][Full Text] [Related]
16. [Antibiotic resistance of Gardnerella vaginalis isolated from cases of bacterial vaginosis].
Tomusiak A; Strus M; Heczko PB
Ginekol Pol; 2011 Dec; 82(12):900-4. PubMed ID: 22384625
[TBL] [Abstract][Full Text] [Related]
17. Response of Gardnerella vaginalis biofilm to 5 days of moxifloxacin treatment.
Swidsinski A; Dörffel Y; Loening-Baucke V; Schilling J; Mendling W
FEMS Immunol Med Microbiol; 2011 Feb; 61(1):41-6. PubMed ID: 20955467
[TBL] [Abstract][Full Text] [Related]
18. Benzoyl Peroxide Inhibits Quorum Sensing and Biofilm Formation by
Algburi A; Zehm S; Netrebov V; Weeks R; Zubovskiy K; Chikindas ML
Infect Dis Obstet Gynecol; 2018; 2018():1426109. PubMed ID: 30057443
[TBL] [Abstract][Full Text] [Related]
19. Use of a continuous-culture biofilm system to study the antimicrobial susceptibilities of Gardnerella vaginalis and Lactobacillus acidophilus.
Muli F; Struthers JK
Antimicrob Agents Chemother; 1998 Jun; 42(6):1428-32. PubMed ID: 9624489
[TBL] [Abstract][Full Text] [Related]
20. Etiology of bacterial vaginosis and polymicrobial biofilm formation.
Jung HS; Ehlers MM; Lombaard H; Redelinghuys MJ; Kock MM
Crit Rev Microbiol; 2017 Nov; 43(6):651-667. PubMed ID: 28358585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
